Cargando…

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation

BACKGROUND: Percutaneous cryoablation (PCA) has emerged as an alternative to extirpative management of small renal masses in select patients. In recent years, the use of targeted therapies has become mainstream, while the role of PCA in treating primary tumor is not well established among patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Cheng-Yuan, Wang, Jun-jie, Zhang, Hai-Liang, Shi, Guo-Hai, Ye, Ding-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565618/ https://www.ncbi.nlm.nih.gov/pubmed/34746004 http://dx.doi.org/10.3389/fonc.2021.762547

Ejemplares similares

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
por: Mohammad, H., et al.
Publicado: (2021)

Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
por: Yoshimura, Akihiro, et al.
Publicado: (2020)

C-Reactive Protein Levels and Survival Following Cytoreductive Nephrectomy in 118 Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Study
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting
por: Nikic, Predrag, et al.
Publicado: (2022)

Erythema multiforme major induced by sunitinib for metastatic renal cell carcinoma
por: Watanabe, Daisuke, et al.
Publicado: (2019)

Sunitinib: An Unusual Cause of Pneumothorax in a Patient With Metastatic Chromophobe Renal Cell Carcinoma
por: Bukhari, Nedal, et al.
Publicado: (2020)

Sunitinib in Metastatic Renal Cell Carcinoma: A Systematic Review of UK Real World Data
por: Argyropulo-Palmer, Miriam, et al.
Publicado: (2015)

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
por: Motzer, R J, et al.
Publicado: (2013)

Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
por: Campbell, Matthew T., et al.
Publicado: (2021)

Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC)
por: Peng, Bo, et al.
Publicado: (2017)

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?
por: Shah, Amishi Y., et al.
Publicado: (2015)

The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib
por: Frees, Sebastian, et al.
Publicado: (2018)

Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib
por: Lee, Alex Q., et al.
Publicado: (2021)

Eosinophil percentage elevation as a prognostic factor for overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
por: Wang, Hong-Kai, et al.
Publicado: (2016)

The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response
por: Wang, Chang, et al.
Publicado: (2023)

Efficacy of sequential therapies with sorafenib-sunitinib versus sunitinib-sorafenib in metastatic renal cell carcinoma: A systematic review and meta-analysis
por: Wen, Tingyu, et al.
Publicado: (2017)

Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective study
por: Zhang, Hai-Liang, et al.
Publicado: (2015)

Conditional disease-free survival in high-risk renal cell carcinoma treated with sunitinib
por: Shao, Ning, et al.
Publicado: (2019)

Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
por: Billemont, B, et al.
Publicado: (2008)

A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib
por: Morizane, Shuichi, et al.
Publicado: (2012)

Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib
por: Fiala, Ondřej, et al.
Publicado: (2021)

Sorafenib versus sunitinib as first-line treatment agents in Chinese patients with metastatic renal cell carcinoma: the largest multicenter retrospective analysis of survival and prognostic factors
por: Zhang, Hai-Liang, et al.
Publicado: (2017)

Radiofrequency ablation and cryoablation of renal tumours
por: Kwan, K.G., et al.
Publicado: (2007)

Sunitinib maleate administration before percutaneous CT-guided cryoablation for large renal cell carcinoma: A case report
por: Nishizawa, Kaori, et al.
Publicado: (2022)

Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?
por: Ucar, Gokhan, et al.
Publicado: (2020)

Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
por: Rini, Brian I., et al.
Publicado: (2011)

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
por: Beuselinck, B, et al.
Publicado: (2013)

Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
por: Keizman, Daniel, et al.
Publicado: (2016)

Acute Acalculous Cholecystitis in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2014)

Metastatic collecting duct carcinoma of the kidney treated with sunitinib
por: Tazi, El Mehdi, et al.
Publicado: (2011)

Safety and effectiveness of percutaneous renal cryoablation with conscious sedation
por: Patel, Sagar Rohitkumar, et al.
Publicado: (2020)

Comparative Efficacy, Safety, and Costs of Sorafenib vs. Sunitinib as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Deng, Huan, et al.
Publicado: (2019)

Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly
por: Huang, Qianwen, et al.
Publicado: (2022)

Efficacy and safety of cryoablation for localized renal tumor as an alternative approach to partial nephrectomy
por: Barjolle, Irène, et al.
Publicado: (2023)

Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes
por: Shi, Hongjin, et al.
Publicado: (2022)

First-line therapy with sunitinib in advanced renal cell carcinoma: interpretation of the overall survival data from asco 2008
por: Wood, L.
Publicado: (2009)

Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients
por: Buda-Nowak, Anna, et al.
Publicado: (2017)

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma
por: Iyer, Ridhima, et al.
Publicado: (2017)

Metastatic Thymic Carcinoma with Long Survival After Treatment with Sunitinib
por: Cabezón-Gutiérrez, Luis, et al.
Publicado: (2018)

Metastatic clear cell renal cell carcinoma to the forearm without identifiable primary renal mass
por: Walton, John, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iiseq1leud48tkf5dofgknuo28